PROTEIN BASED PHARMACEUTICAL PROMOTE BONE

Brand	Owner (click to sort)	Address	Description
FACEREL	GENETICS INSTITUTE, INC.	87 CambridgePark Drive Cambridge MA 02140	Protein-based pharmaceutical to promote bone cell growth;Surgically implanted bone growth protein device;
MAXELOS	AMERICAN HOME PRODUCTS CORPORATION	New York NY	Protein-based pharmaceutical to promote bone cell growth;
VIGENOS	WYETH	Five Giralda Farms Madison NJ 07940	Protein-based pharmaceutical to promote bone cell growth;Bone cell growth protein-based implants;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

An agent for treatment of metabolic bone disease, which contains EPO as an active ingredient, or a method for treating a patient with metabolic bone disease, which comprises EPO, is provided. Pharmaceutical products containing EPO as the active ingredient are novel prophylactic and therapeutic agents which show an ameliorative action by healing bone and bone marrow lesions in bone disease, especially bone disease based on impaired bone metabolism, aside from the previously reported erythrocyte increasing action of EPO. Pathological states, targeted by these pharmaceutical products, are bone diseases showing metabolic bone disorders, including renal failure-associated osteodystrophy, marble bone disease, diabetic nephropathy, and osteoporosis.